C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast.
Open Access
- 1 September 1986
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 103 (3), 1091-1100
- https://doi.org/10.1083/jcb.103.3.1091
Abstract
Many hemopoietic cell lines were examined for their ability to adhere to culture dishes coated with extracellular matrix proteins. Adhesion assay was performed with murine and human leukemic cell lines representative of different stages of differentiation along both erythroid and myeloid lineages. All the hemopoietic cell lines tested adhered to fibronectin but not to laminin, types I, III, and IV collagen, serum-spreading factor, and cartilage proteoglycans. In addition to immortalized cell lines, immature erythroid and myeloid mouse bone marrow cells adhered to fibronectin. To define the fibronectin region involved in hemopoietic cell adhesion, proteolytic fragments, monoclonal antibodies, and synthetic peptides were used. Among different fibronectin fragments tested, only a 110-kD polypeptide, corresponding to the fibroblast attachment domain, was active in promoting adhesion. Moreover, a monoclonal antibody to the cell binding site located within this domain prevented hemopoietic cell adhesion. Finally, the tetrapeptide Arg-Gly-Asp-Ser, which corresponds to the fibronectin sequence recognized by fibroblastic cells, specifically and competitively inhibited attachment of hemopoietic cells to this molecule. The cell surface molecule involved in the interaction of mouse hemopoietic cells with fibronectin was identified as a 145,000-D membrane glycoprotein by adhesion-blocking antibodies. This glycoprotein was found to be antigenically and functionally related to the GP135 membrane glycoprotein involved in the adhesion of fibroblasts to fibronectin (Giancotti, F. G., P. M. Comoglio, and G. Tarone, 1986, Exp. Cell Res., 163:47-62). On the basis of these data, we conclude that interaction of hemopoietic cells with fibronectin involves a specific fibronectin sequence and a 145,000-D cell surface glycoprotein. We speculate that this property might be relevant for the interaction of hemopoietic cells with the bone marrow stroma, which represents the natural site of hemopoiesis.This publication has 36 references indexed in Scilit:
- The alternative pathway of complementSpringer Seminars in Immunopathology, 1984
- Basement membrane diversity detected by monoclonal antibodiesDifferentiation, 1984
- Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.The Journal of Experimental Medicine, 1982
- A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitroEuropean Journal of Immunology, 1981
- GLOMERULAR IMMUNE DEPOSITS IN KIDNEYS FROM PATIENTS WITH NO CLINICAL OR LIGHT MICROSCOPIC EVIDENCE OF GLOMERULONEPHRITIS Assessment of the Influence of Autolysis on Identification of Immunoglobulins and ComplementActa Pathologica Microbiologica Scandinavica Section A Pathology, 1979
- C3 component of complement secreted by established cell linesCell, 1978
- Immunobiology of the human placenta: II. Localization of macrophages, in vivo bound IgG and C3Cellular Immunology, 1978
- Binding of soluble form of fibroblast surface protein, fibronectin, to collagenInternational Journal of Cancer, 1977
- Immunochemical demonstration of serum β2-glycoprotein III in normal and diseased human glomeruliClinical Immunology and Immunopathology, 1976
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969